Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    16406806 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Condition: Multiple Sclerosis
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone;   Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM);   Procedure: Autologous hematopoietic stem cell transplant

Indicates status has not been verified in more than two years